Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric L Simpson

Showing results (11-20 of 314) with videos related to

Pageof 32
Sort By:
Journal of the American Academy of Dermatology|June 21, 2005
Atopic dermatitisEric L Simpson, Jon M Hanifin
The Medical Clinics of North America|November 29, 2005
Atopic dermatitisEric L Simpson, Jon M Hanifin
Journal of the American Academy of Dermatology|April 17, 2017
Reply to: "Conclusions about atopic dermatitis persistence might be premature"Jonathan I Silverberg, Eric L Simpson
Journal of the American Academy of Dermatology|April 17, 2017
Reply to: "Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis alters interpretation"Jonathan I Silverberg, Eric L Simpson
Dermatitis : Contact, Atopic, Occupational, Drug|May 14, 2014
Associations of childhood eczema severity: a US population-based studyJonathan I Silverberg, Eric L Simpson
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 19, 2013
Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilizationJonathan I Silverberg, Eric L Simpson
The Journal of Allergy and Clinical Immunology|June 9, 2015
Reply: To PMID 25282563Eric L Simpson, Hywel Williams, Joanne Chalmers
American Journal of Clinical Dermatology|April 24, 2020
New and Emerging Biologics for Atopic DermatitisWenelia Baghoomian, ChanHo Na, Eric L Simpson
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|January 28, 2004
A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitisEric L Simpson, Matthew Basco, Jon Hanifin
The New England Journal of Medicine|March 16, 2017
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisEric L Simpson, Bolanle Akinlade, Marius Ardeleanu
Pageof 32

Showing results (11-20 of 314) with videos related to

Sort By:
Pageof 32
Journal of the American Academy of Dermatology|June 21, 2005
Atopic dermatitisEric L Simpson, Jon M Hanifin
The Medical Clinics of North America|November 29, 2005
Atopic dermatitisEric L Simpson, Jon M Hanifin
Journal of the American Academy of Dermatology|April 17, 2017
Reply to: "Conclusions about atopic dermatitis persistence might be premature"Jonathan I Silverberg, Eric L Simpson
Journal of the American Academy of Dermatology|April 17, 2017
Reply to: "Heterogeneity of data included in meta-analysis on persistence of atopic dermatitis alters interpretation"Jonathan I Silverberg, Eric L Simpson
Dermatitis : Contact, Atopic, Occupational, Drug|May 14, 2014
Associations of childhood eczema severity: a US population-based studyJonathan I Silverberg, Eric L Simpson
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 19, 2013
Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilizationJonathan I Silverberg, Eric L Simpson
The Journal of Allergy and Clinical Immunology|June 9, 2015
Reply: To PMID 25282563Eric L Simpson, Hywel Williams, Joanne Chalmers
American Journal of Clinical Dermatology|April 24, 2020
New and Emerging Biologics for Atopic DermatitisWenelia Baghoomian, ChanHo Na, Eric L Simpson
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|January 28, 2004
A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitisEric L Simpson, Matthew Basco, Jon Hanifin
The New England Journal of Medicine|March 16, 2017
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisEric L Simpson, Bolanle Akinlade, Marius Ardeleanu
Pageof 32